Novated and Restated Technology License Agreement Sample Contracts

NOVATED AND RESTATED TECHNOLOGY LICENSE AGREEMENT dated as of December 1, 2006 among ALEXZA PHARMACEUTICALS, INC., SYMPHONY ALLEGRO, INC. and SYMPHONY ALLEGRO HOLDINGS LLC

Novated and Restated Technology License Agreement • March 29th, 2007 • Alexza Pharmaceuticals Inc. • Pharmaceutical preparations • New York

• Contract Type
  Novated and Restated Technology License Agreement
• Filed
  March 29th, 2007
• Company
  Alexza Pharmaceuticals Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This NOVATED AND RESTATED TECHNOLOGY LICENSE AGREEMENT (this “Agreement”) is made and effective as of December 1, 2006, by and among Alexza Pharmaceuticals, Inc., a Delaware corporation (the “Licensor”), Symphony Allegro, Inc., a Delaware corporation (“Symphony Allegro”) (each of Licensor and Symphony Allegro being a “Party,” and collectively, the “Parties”), and Symphony Allegro Holdings LLC, a Delaware limited liability company (“Holdings”).

NOVATED AND RESTATED TECHNOLOGY LICENSE AGREEMENT dated as of June 17, 2004 between GPI NIL HOLDINGS, INC., GUILFORD PHARMACEUTICALS INC., SYMPHONY NEURO DEVELOPMENT COMPANY and SNDC HOLDINGS LLC

Novated and Restated Technology License Agreement • June 21st, 2004 • Guilford Pharmaceuticals Inc • Pharmaceutical preparations • New York

• Contract Type
  Novated and Restated Technology License Agreement
• Filed
  June 21st, 2004
• Company
  Guilford Pharmaceuticals Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This NOVATED AND RESTATED TECHNOLOGY LICENSE AGREEMENT (this “Agreement”) is made and effective as of June 17, 2004 (the “Effective Date”) by and between GPI NIL Holdings, Inc., a Delaware corporation (“GPI”), Guilford Pharmaceuticals Inc., a Delaware corporation (“Guilford,” and together with GPI, “Licensor”), Symphony Neuro Development Company, a Delaware corporation (“SNDC”) (each of Licensor and SNDC being a “Party,” and collectively, the "Parties”), and SNDC Holdings LLC, a Delaware limited liability company (“Holdings”).

NOVATED AND RESTATED TECHNOLOGY LICENSE AGREEMENT among OXiGENE, INC., SYMPHONY ViDA, INC. and SYMPHONY ViDA HOLDINGS LLC Dated as of October 1, 2008

Novated and Restated Technology License Agreement • October 10th, 2008 • Oxigene Inc • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Novated and Restated Technology License Agreement
• Filed
  October 10th, 2008
• Company
  Oxigene Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

This NOVATED AND RESTATED TECHNOLOGY LICENSE AGREEMENT (this “Agreement”) is made and effective as of October 1, 2008 by and among OXiGENE, Inc., a Delaware corporation (the “Licensor”), Symphony ViDA, Inc., a Delaware corporation (the “Symphony Collaboration”) (each of Licensor and the Symphony Collaboration being a “Party,” and collectively, the “Parties”), and Symphony ViDA Holdings LLC, a Delaware limited liability company (“Holdings”).